European Pharmaceutical Review

FEBRUARY 2, 2023

Alarmingly, there are now 93 active ingredients for which no European company holds a certificate. This reliance on sourcing API from other nations puts Europe’s entire manufacturing cycle at risk, especially in the event of global crises and geopolitical tensions.

Generic Medicine 99

Generic Medicine Packaging Documentation Pharmaceutical Companies 99

pharmaphorum

MAY 26, 2022

Within pharma and healthcare, where greater representation has been proven to lead to better health outcomes for all patients and the pharmaceutical companies developing medicines, change is also happening. As a Non-Clinical Assessor at MHRA he assessed non-clinical data packages for new and generic medicines.

Packaging 138

Packaging Vaccines Generic Medicine Compounding 138

Pharmaceutical Technology

DECEMBER 19, 2022

While the ripple effect of such an event is expected across sectors, in the pharmaceutical arena, small and mid-sized enterprises (SMEs) are predicted to be heavily impacted as the economic downturn affects plans to raise capital, amongst other things. JP Morgan predicts that the US unemployment rate could rise to 4.3%

Pharmaceutical Companies 69

Pharmaceutical Companies Pharmaceutical Companies Generic Medicine Communication 69